NS5 of dengue virus mediates STAT2 binding and degradation
- PMID: 19279106
- PMCID: PMC2681973
- DOI: 10.1128/JVI.02188-08
NS5 of dengue virus mediates STAT2 binding and degradation
Abstract
The mammalian interferon (IFN) signaling pathway is a primary component of the innate antiviral response. As such, viral pathogens have devised multiple mechanisms to antagonize this pathway and thus facilitate infection. Dengue virus (DENV) encodes several proteins (NS2a, NS4a, and NS4b) that have been shown individually to inhibit the IFN response. In addition, DENV infection results in reduced levels of expression of STAT2, which is required for IFN signaling (M. Jones, A. Davidson, L. Hibbert, P. Gruenwald, J. Schlaak, S. Ball, G. R. Foster, and M. Jacobs, J. Virol. 79:5414-5420, 2005). Translation of the DENV genome results in a single polypeptide, which is processed by viral and host proteases into at least 10 separate proteins. To date, no single DENV protein has been implicated in the targeting of STAT2 for decreased levels of expression. We demonstrate here that the polymerase of the virus, NS5, binds to STAT2 and is necessary and sufficient for its reduced level of expression. The decrease in protein level observed requires ubiquitination and proteasome activity, strongly suggesting an active degradation process. Furthermore, we show that the degradation of but not binding to STAT2 is dependent on the expression of the polymerase in the context of a polyprotein that undergoes proteolytic processing for NS5 maturation. Thus, the mature form of NS5, when not expressed as a precursor, was able to bind to STAT2 but was unable to target it for degradation, establishing a unique role for viral polyprotein processing in providing an additional function to a viral polypeptide. Therefore, we have identified both a novel mechanism by which DENV evades the innate immune response and a potential target for antiviral therapeutics.
Figures
Similar articles
-
Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.J Virol. 2019 Jun 28;93(14):e00151-19. doi: 10.1128/JVI.00151-19. Print 2019 Jul 15. J Virol. 2019. PMID: 31043530 Free PMC article.
-
Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.J Interferon Cytokine Res. 2015 Jun;35(6):421-30. doi: 10.1089/jir.2014.0129. Epub 2015 Jan 28. J Interferon Cytokine Res. 2015. PMID: 25629430 Free PMC article. Review.
-
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.PLoS Pathog. 2013 Mar;9(3):e1003265. doi: 10.1371/journal.ppat.1003265. Epub 2013 Mar 28. PLoS Pathog. 2013. PMID: 23555265 Free PMC article.
-
Innate immunity evasion by Dengue virus.Viruses. 2012 Mar;4(3):397-413. doi: 10.3390/v4030397. Epub 2012 Mar 15. Viruses. 2012. PMID: 22590678 Free PMC article. Review.
-
Mouse STAT2 restricts early dengue virus replication.Cell Host Microbe. 2010 Nov 18;8(5):410-21. doi: 10.1016/j.chom.2010.10.007. Cell Host Microbe. 2010. PMID: 21075352 Free PMC article.
Cited by
-
The Dynamic Relationship between Dengue Virus and the Human Cutaneous Innate Immune Response.Viruses. 2024 May 4;16(5):727. doi: 10.3390/v16050727. Viruses. 2024. PMID: 38793609 Free PMC article. Review.
-
Residue K28 of Zika Virus NS5 Protein Is Implicated in Virus Replication and Antagonism of STAT2.Microorganisms. 2024 Mar 26;12(4):660. doi: 10.3390/microorganisms12040660. Microorganisms. 2024. PMID: 38674605 Free PMC article.
-
Dengue virus pathogenesis and host molecular machineries.J Biomed Sci. 2024 Apr 22;31(1):43. doi: 10.1186/s12929-024-01030-9. J Biomed Sci. 2024. PMID: 38649998 Free PMC article. Review.
-
Cross Talk between MicroRNAs and Dengue Virus.Am J Trop Med Hyg. 2024 Apr 2;110(5):856-867. doi: 10.4269/ajtmh.23-0546. Print 2024 May 1. Am J Trop Med Hyg. 2024. PMID: 38579704 Review.
-
ISG15/USP18/STAT2 is a molecular hub regulating IFN I-mediated control of Dengue and Zika virus replication.Front Immunol. 2024 Feb 7;15:1331731. doi: 10.3389/fimmu.2024.1331731. eCollection 2024. Front Immunol. 2024. PMID: 38384473 Free PMC article.
References
-
- Ashburn, P. M., and C. F. Craig. 1907. Experimental investigations regarding the etiology of dengue fever. J. Infect. Dis. 4440-475. - PubMed
-
- Best, S. M., K. L. Morris, J. G. Shannon, S. J. Robertson, D. N. Mitzel, G. S. Park, E. Boer, J. B. Wolfinbarger, and M. E. Bloom. 2005. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 7912828-12839. - PMC - PubMed
-
- Cleary, C. M., R. J. Donnelly, J. Soh, T. M. Mariano, and S. Pestka. 1994. Knockout and reconstitution of a functional human type I interferon receptor complex. J. Biol. Chem. 26918747-18749. - PubMed
-
- Cleaves, G. R., and D. T. Dubin. 1979. Methylation status of intracellular dengue type 2 40 S RNA. Virology 96159-165. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous